Research ArticleSpecial Contribution
MIRD Pamphlet No. 25: MIRDcell V2.0 Software Tool for Dosimetric Analysis of Biologic Response of Multicellular Populations
Behrooz Vaziri, Han Wu, Atam P. Dhawan, Peicheng Du, Roger W. Howell and In collaboration with the SNMMI MIRD Committee:
Journal of Nuclear Medicine September 2014, 55 (9) 1557-1564; DOI: https://doi.org/10.2967/jnumed.113.131037
Behrooz Vaziri
1Division of Radiation Research, Department of Radiology, New Jersey Medical School, Rutgers, The State University of New Jersey, Newark, New Jersey
Han Wu
1Division of Radiation Research, Department of Radiology, New Jersey Medical School, Rutgers, The State University of New Jersey, Newark, New Jersey
2Office of Research and Department of Microbiology, New Jersey Medical School, Rutgers, The State University of New Jersey, Newark, New Jersey
3Department of Electrical and Computer Engineering, New Jersey Institute of Technology, Newark, New Jersey; and
Atam P. Dhawan
3Department of Electrical and Computer Engineering, New Jersey Institute of Technology, Newark, New Jersey; and
Peicheng Du
4High Performance and Research Computing, IST, Rutgers Biomedical and Health Sciences, Rutgers, The State University of New Jersey, Newark, New Jersey
Roger W. Howell
1Division of Radiation Research, Department of Radiology, New Jersey Medical School, Rutgers, The State University of New Jersey, Newark, New Jersey
Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 55, Issue 9
September 1, 2014
MIRD Pamphlet No. 25: MIRDcell V2.0 Software Tool for Dosimetric Analysis of Biologic Response of Multicellular Populations
Behrooz Vaziri, Han Wu, Atam P. Dhawan, Peicheng Du, Roger W. Howell, In collaboration with the SNMMI MIRD Committee:
Journal of Nuclear Medicine Sep 2014, 55 (9) 1557-1564; DOI: 10.2967/jnumed.113.131037
MIRD Pamphlet No. 25: MIRDcell V2.0 Software Tool for Dosimetric Analysis of Biologic Response of Multicellular Populations
Behrooz Vaziri, Han Wu, Atam P. Dhawan, Peicheng Du, Roger W. Howell, In collaboration with the SNMMI MIRD Committee:
Journal of Nuclear Medicine Sep 2014, 55 (9) 1557-1564; DOI: 10.2967/jnumed.113.131037
Jump to section
Related Articles
Cited By...
- The MIRD Schema for Radiopharmaceutical Dosimetry: A Review
- Development and Preclinical Evaluation of [211At]PSAt-3-Ga: An Inhibitor for Targeted {alpha}-Therapy of Prostate Cancer
- Gadolinium-Based Nanoparticles Sensitize Ovarian Peritoneal Carcinomatosis to Targeted Radionuclide Therapy
- [123I]CC1: A PARP-Targeting, Auger Electron-Emitting Radiopharmaceutical for Radionuclide Therapy of Cancer
- Efficacy of HER2-Targeted Intraperitoneal 225Ac {alpha}-Pretargeted Radioimmunotherapy for Small-Volume Ovarian Peritoneal Carcinomatosis
- Marshalling the Potential of Auger Electron Radiopharmaceutical Therapy
- MIRD Pamphlet No. 28, Part 1: MIRDcalc--A Software Tool for Medical Internal Radiation Dosimetry
- Dosimetry in Radiopharmaceutical Therapy
- MIRD Pamphlet No. 27: MIRDcell V3, a Revised Software Tool for Multicellular Dosimetry and Bioeffect Modeling
- Modeling Early Radiation DNA Damage Occurring During 177Lu-DOTATATE Radionuclide Therapy
- Dosimetry for Radiopharmaceutical Therapy: Current Practices and Commercial Resources
- Overview of the First NRG Oncology-National Cancer Institute Workshop on Dosimetry of Systemic Radiopharmaceutical Therapy
- Targeted Brain Tumor Radiotherapy Using an Auger Emitter
- PARP-1-Targeted Auger Emitters Display High-LET Cytotoxic Properties In Vitro but Show Limited Therapeutic Utility in Solid Tumor Models of Human Neuroblastoma
- PARaDIM: A PHITS-Based Monte Carlo Tool for Internal Dosimetry with Tetrahedral Mesh Computational Phantoms
- Targeting Micrometastases: The Effect of Heterogeneous Radionuclide Distribution on Tumor Control Probability
- Antibody with Infinite Affinity for In Vivo Tracking of Genetically Engineered Lymphocytes
- Monte Carlo N-Particle (MCNP) Modeling of the Cellular Dosimetry of 64Cu: Comparison with MIRDcell S Values and Implications for Studies of Its Cytotoxic Effects
- 124I PET Assessment of Response of Bone Metastases to Initial Radioiodine Treatment of Differentiated Thyroid Cancer
- Biokinetic Modeling and Dosimetry for Optimizing Intraperitoneal Radioimmunotherapy of Ovarian Cancer Microtumors
- Comparison of the Therapeutic Response to Treatment with a 177Lu-Labeled Somatostatin Receptor Agonist and Antagonist in Preclinical Models
- Nanoconjugation of PSMA-Targeting Ligands Enhances Perinuclear Localization and Improves Efficacy of Delivered Alpha-Particle Emitters against Tumor Endothelial Analogues
- Monte Carlo Evaluation of Auger Electron-Emitting Theranostic Radionuclides
- Proceedings of the Second NCI-SNMMI Workshop on Targeted Radionuclide Therapy